Migdal Insurance & Financial Holdings’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
Migdal Insurance & Financial Holdings's ARKG Position: Q3 2022 in Review
Migdal Insurance & Financial Holdings sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2022, closing a stake of 375 shares — an estimated $12K sold.
Migdal Insurance & Financial Holdings first reported a position in ARKG in Q1 2019 and held it in 14 quarters. The position peaked at $1.81M in Q2 2021. 312 funds tracked by Wall St. Rank hold ARKG as of Q3 2022.
- Migdal Insurance & Financial Holdings reported no remaining ARK Genomic Revolution ETF position as of Q3 2022 after selling out during the quarter.
- Migdal Insurance & Financial Holdings sold 375 ARK Genomic Revolution ETF shares in Q3 2022, an estimated $12K.
- Migdal Insurance & Financial Holdings first reported a position in ARK Genomic Revolution ETF in Q1 2019 and held it in 14 quarters.
- Migdal Insurance & Financial Holdings's ARK Genomic Revolution ETF position peaked at $1.81M in Q2 2021.
- 312 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2022.
Based on Migdal Insurance & Financial Holdings's 13F filing for Q3 2022, filed 31 Oct 2022.